Medication info
Hipoten Tablet 160/12.5 mg

Hipoten Tablet 160/12.5 mg

Prescription medicationTabletOral
Ingredient · strength
Valsartan›160mg / 1 tabletHydrochlorothiazide›12.5mg / 1 tablet
Manufacturer / importer
Donggu Bio Pharmaceutical Co., Ltd.
Appearance
Dark reddish oval film-coated tablets
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201708331 · Approved 2017.12.12

Summary

Main use
Treatment of essential hypertension not controlled with monotherapy
Who takes it
Adults
Adult dose
○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg for blood pressure reduction. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance ≥30 mL/min). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Ingredients

Manufacturer
Donggu Bio Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of essential hypertension not controlled with monotherapy

  • Essential hypertension
View approved original text

This medication is used for patients with essential hypertension who do not have sufficient blood pressure control with monotherapy. Essential hypertension is high blood pressure that occurs without a specific cause and can increase the risk of heart disease or stroke. Therefore, this medication helps effectively lower blood pressure and prevent cardiovascular complications. If taken according to the prescription of the attending physician, it will help control blood pressure.

How to take

Adult dose

○ Adults The recommended dose is 1 tablet of valsartan 80 mg/hydrochlorothiazide 12.5 mg once daily. It may be taken with or without food, with a small amount of water. Valsartan 160 mg/hydrochlorothiazide 12.5 mg is for patients prescribed valsartan 160 mg/hydrochlorothiazide 12.5 mg for blood pressure reduction. The maximum blood pressure-lowering effect is achieved after 2 ~ 4 weeks. ○ Patients with renal impairment No dose adjustment is necessary in patients with mild ~ moderate renal impairment (creatinine clearance ≥30 mL/min). ○ Patients with hepatic impairment In patients with mild ~ moderate hepatic impairment without cholestasis, do not use more than 80 mg of valsartan per day.

Precautions

This medicine can cause serious harm to the fetus if used during pregnancy, especially in the second and third trimesters, so women who are pregnant or may become pregnant should not take it. Patients with an allergy to any of the ingredients in this medicine or those with certain liver or kidney disorders should not take it. Patients with severely impaired kidney function or certain electrolyte imbalances should also not use this medication. Dizziness or symptoms of low blood pressure may occur during use, so caution is needed, especially when starting treatment. Potassium levels may change, so potassium supplements or potassium-containing foods and medications should not be taken without consulting a physician. This medication may affect liver and kidney function, so it is important to regularly check function through blood tests, etc. Caution is needed when driving or operating machinery, as dizziness or drowsiness may occur. This medication may interact with other medications, so if you are taking other drugs, be sure to inform your doctor or pharmacist. Skin reactions may occur, or sensitivity to sunlight may increase, so avoid sun exposure and consult a doctor immediately if there are any skin changes. In the case of overdose, symptoms such as low blood pressure, muscle cramps, or drowsiness may occur, so the dosage must be adhered to, and if abnormal symptoms arise, seek medical help immediately. For children and the elderly, special caution is needed as the safety and efficacy of this medication have not been fully established.

Side effects

Headache, dizziness, nasopharyngitis, fatigue, low back pain, cough, upper respiratory tract infection, diarrhea, arthralgia, abdominal pain, epigastric pain, blurred vision, visual disturbances, anxiety, arthritis, bronchitis, acute bronchitis, chest pain, orthostatic dizziness, dry mouth, dyspepsia, shortness of breath, erectile dysfunction, enterocolitis, hyperhidrosis, sensory loss, insomnia, hypokalemia, hypotension, influenza, muscle cramps, muscle strain, nausea, nasal congestion, nasal bleeding, throat pain, otitis media, limb pain, paresthesia, pharyngodynia, fever, sinus congestion, sinusitis, drowsiness, leg cramps, frequent urination, palpitations, rash, ligament strain, syncope, tachycardia, tinnitus, urinary tract infection, viral infection, edema, peripheral edema, weakness, angioedema, itching, serum sickness, vasculitis, hair loss, renal function impairment, myalgia, symptoms resembling anaphylaxis, hepatitis, renal failure, hyperkalemia, hyponatremia, shock, loss of consciousness, agranulocytosis, leukopenia, thrombocytopenia, aplastic anemia, hemolytic anemia, necrotizing vasculitis, toxic epidermal necrolysis, interstitial pneumonia, pulmonary edema, systemic lupus erythematosus exacerbation, hypoglycemia, rhabdomyolysis, elevated AST, palpitations, dyspepsia, decreased hemoglobin, decreased hematocrit, increased serum potassium, vertigo, vasculitis, elevated liver function tests, angioedema, rash, vesicular dermatitis, renal failure, hypokalemia, elevated blood lipids, hyponatremia, hypomagnesemia, hyperuricemia, hypercalcemia, hypochloremic alkalosis, hyperglycemia, diabetes, deterioration of diabetic metabolism, urticaria, skin rash, photosensitivity reaction, necrotizing vasculitis, cutaneous lupus erythematosus, decreased appetite, nausea, vomiting, abdominal discomfort, constipation, diarrhea, gastrointestinal discomfort, pancreatitis, intrahepatic cholestasis, jaundice, orthostatic hypotension, cardiac arrhythmias, sensory loss, sedation, sleep disorders, depression, paresthesia, visual impairment, thrombocytopenia, leukopenia, agranulocytosis, bone marrow dysfunction, hemolytic anemia, acute respiratory distress syndrome, hypersensitivity reaction, pneumonia, pulmonary edema, arthralgia, weakness, low back pain, dizziness, headache, insomnia, decreased libido, nausea, edema, pharyngitis, rhinitis, sinusitis, upper respiratory infection, viral infection, intestinal vascular edema, nausea, drowsiness, hypovolemia, arrhythmia, muscle spasm, hypotension, hypoglycemia, asthenia, hunger, diaphoresis, hand tremors, decreased concentration, convulsions, altered consciousness

Not everyone experiences these, and they can vary from person to person.

Storage

This medicine should be stored in a tightly closed container to protect it from air and moisture, and it is best to store it at a cool temperature below 30 degrees Celsius. Proper storage will maintain the effectiveness of the medication for a long time.

Appearance and packaging

Appearance

Dark reddish oval film-coated tablets

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.